Your session is about to expire
← Back to Search
Quitbuddy App + Support for Smoking Cessation
N/A
Waitlist Available
Led By Bryan W Heckman, Ph.D.
Research Sponsored by Bryan W. Heckman
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured one day after a participant's target quit-date.
Awards & highlights
Study Summary
This trial will test if a smoker can quit and stay quit with an app and help with social and financial needs. Participants will get nicotine lozenges and check in with researchers to report quitting progress.
Who is the study for?
This trial is for English/Spanish-speaking adults over 21 who smoke at least 10 cigarettes daily for the past year and are ready to quit within a week using nicotine replacement therapy. It's not for those pregnant, breastfeeding, with recent heart issues or strokes, or using other tobacco products or cessation meds.Check my eligibility
What is being tested?
The study tests Quitbuddy, a GPS-enabled app designed to help smokers quit and prevent relapse. It will be compared with another app by the National Cancer Institute. Participants also receive social/financial support to see if it enhances Quitbuddy's effectiveness.See study design
What are the potential side effects?
While this trial primarily involves digital apps which do not have direct side effects like medications might, participants may experience typical nicotine withdrawal symptoms due to quitting smoking such as irritability, cravings, or difficulty concentrating.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured one day after a participant's target quit-date.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured one day after a participant's target quit-date.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Abstinence Rate
Cravings
NRT Compliance
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: QuitbuddyExperimental Treatment3 Interventions
Participants will be assigned to use a smartphone app (QuitBuddy) that will automatically guide NRT treatment delivery through the integration of ecological momentary assessments (EMA) and GPS into personalized relapse prevention algorithms.
Group II: ControlActive Control3 Interventions
Control is intended to approximate the real-world experience where Participants will use The National Cancer Institute's smartphone app (QuitGuide) and will self-manage NRT treatment delivery based on written instructions.
Find a Location
Who is running the clinical trial?
Bryan W. HeckmanLead Sponsor
City of Hope Medical CenterOTHER
565 Previous Clinical Trials
1,919,370 Total Patients Enrolled
1 Trials studying Tobacco Use Disorder
100 Patients Enrolled for Tobacco Use Disorder
Virginia Tech Carilion School of Medicine and Research InstituteOTHER
6 Previous Clinical Trials
468 Total Patients Enrolled
1 Trials studying Tobacco Use Disorder
65 Patients Enrolled for Tobacco Use Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am ready to try quitting smoking with NRT within a week.I have not had a heart attack or stroke in the last 3 months.I have used alternative tobacco products or smoking cessation aids in the last 30 days.I am 21 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Quitbuddy
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still vacancy slots available for participants in this scientific research?
"The information listed on clinicaltrials.gov reveals that, as of November 21st 2022, this trial is no longer recruiting patients. The study first posted an invitation to participate on January 1st 2023 and was last updated in the prior month. However, 111 other studies are presently seeking candidates for participation at this time"
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger